Moderate to severe psoriasis treatment challenges through the era of biological drugs
AUTOR(ES)
Vide, Júlia, Magina, Sofia
FONTE
An. Bras. Dermatol.
DATA DE PUBLICAÇÃO
2017-10
RESUMO
Abstract: Biological therapy has revolutionized moderate to severe psoriasis treatment. However, despite being more effective than conventional systemic treatments, some patients do not respond or lose response to biotechnological treatments or develop drug-antibodies, interfering with its safety and efficacy. There are also clinical forms of the disease and patient profiles for which is pending further scientific evidence for more sustained therapeutic interventions. The continuous and more detailed knowledge of psoriasis pathophysiology has allowed identifying new therapeutic targets, which is expected to help overcome the challenges of individualized psoriasis treatment.
Documentos Relacionados
- Moderate to severe plaque psoriasis - treatment with drugs of the classic scheme
- Biological therapy in the treatment of moderate-to-severe ulcerative colitis patients: can colectomy be prevented?
- Therapeutic response and survival time of immunobiologicals in patients with moderate to severe psoriasis
- Distribution pattern of psoriasis, anxiety and depression as possible causes of sexual dysfunction in patients with moderate to severe psoriasis
- Psoriasis in moderate grave plaque - immunobiological treatment
